4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001171843-16-011868
Director sold 18,062 shares at an average $7.93 ($143,156)
From the SEC's structured data for this filing
Trades in this filing
HOLLER FRANK A · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-08-16 | Sale : show line 1 in the form | −6,863 | $8.25 | $56,620 | 169,006 | D |
| 2016-08-17 | Sale : show line 2 in the form | −1,600 | $7.89 | $12,624 | 167,406 | D |
| 2016-08-18 | Sale : show line 3 in the form | −9,599 | $7.70 | $73,912 | 157,807 | D |
| Open-market sales · 18,062 sh · avg $7.93 · $143,156 | ||||||
Loading xslF345X03/f4_holler081816.xml…